An evaluation of neoadjuvant chemoradiotherapy for patients with resectable pancreatic ductal adenocarcinoma.

about

An evaluation of neoadjuvant chemoradiotherapy for patients with resectable pancreatic ductal adenocarcinoma.

Item

http://www.wikidata.org/entity/Q41891250

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

An evaluation of neoadjuvant c ...... creatic ductal adenocarcinoma.

@en

type

Item

label

An evaluation of neoadjuvant c ...... creatic ductal adenocarcinoma.

@en

prefLabel

An evaluation of neoadjuvant c ...... creatic ductal adenocarcinoma.

@en

P1476

An evaluation of neoadjuvant c ...... ncreatic ductal adenocarcinoma

@en

P2093

Cheng Chen

http://www.w3.org/2001/XMLSchema#string

Chi Du

http://www.w3.org/2001/XMLSchema#string

Hai He

http://www.w3.org/2001/XMLSchema#string

Hong Wu

http://www.w3.org/2001/XMLSchema#string

Jianguo Qiu

http://www.w3.org/2001/XMLSchema#string

Mingwei Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Chemoradiotherapy in the management of localized tumors of the pancreas.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

One thousand consecutive pancreaticoduodenectomies.

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

Neoadjuvant therapy for resectable pancreatic cancer.

Neoadjuvant therapy for pancreatic cancer: the Duke experience.

The case for adjuvant chemotherapy in pancreatic cancer.

P304

298726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/298726

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Hui Jiang

P577

2013-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249998119

http://www.w3.org/2001/XMLSchema#string

P698

23864756

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3705743

http://www.w3.org/2001/XMLSchema#string